Add-On Deals Will Drive 2024 Middle Market M&A
South Florida Investment Bank Cofounder on 2024
Cassel Salpeter chairman sees middle market deal opportunities ahead
Author Archive for: Walker.Matzko
Entries by Walker Matzko
Biotech Gets Creative to Avoid Bankruptcy in 2024
South Florida Investment Bankers on Biotech Bear Market
Cassel Salpeter’s experts on how biotech companies can navigate tough market
Athersys Adds to Surge of Biotechs Filing for Bankruptcy, Sells to Healios
South Florida Investment Banker on Biotech Bankruptcies
Cassel Salpeter investment banker on factors driving biotech Ch. 11
Q4 2023: Tech Deal Report
Miami Investment Banking Firm Cassel Salpeter Releases Tech Industry Deal Report
South Florida firm publishes Q4 2023 Tech Investment Banking Report surveying technology deals, industry M&A, and public markets activity
Bird Enters into Comprehensive Restructuring Support Agreement with First- and Second-Lien Lenders to Strengthen Financial Position
Bird has sufficient liquidity to meet financial obligations to city partners, vendors, suppliers, and employees during and after the restructuring process, and will operate as usual Agreement has unanimous support of first- and second-lien lenders Apollo Global Management and second-lien lenders to provide $25 million in DIP financing
Cassel Salpeter & Co. Advises in Sale of Premier Life Safety Solutions Provider SLS Consulting, LLC, to SOCOTEC USA
Cassel Salpeter & Co. (“Cassel Salpeter”), an independent investment banking firm that provides advisory services to middle market and emerging growth companies in the United States and worldwide, today announced that it has successfully facilitated the sale of industry leader SLS Consulting, LLC (“SLS”), which delivers creative and critical life and fire safety solutions, in its sale to SOCOTEC USA (“SOCOTEC”).
Cassel Salpeter & Co. Facilitates Sale of Athenex Generic Injectable Assets to Sagent Pharmaceuticals in Global Biotech Firm’s Ch. 11 Bankruptcy
Cassel Salpeter & Co., an independent investment banking firm that provides advisory services to middle market and emerging growth companies in the United States and worldwide, today announced that it has successfully facilitated the sale of certain assets of Athenex, Inc. (“Athenex”), a broadly diversified global biopharmaceutical company.
Cassel Salpeter & Co. Serves as Financial Advisor in Sale of P3 Technologies, LLC to Graham Corporation (NYSE: GHM)
Cassel Salpeter & Co., an independent investment banking firm that provides advisory services to middle market and emerging growth companies in the United States and worldwide, today announced that it has successfully advised P3 Technologies (“P3”), a custom turbomachinery engineering, product development and manufacturing business in its sale to Graham Corporation (NYSE:GHM) (“Graham”).
Healthcare Report Q3 2023
Miami Investment Banking Firm Cassel Salpeter Issues Healthcare Industry Deal Report
South Florida firm publishes Q3 2023 Healthcare Deal Report surveying year’s company M&A, deal flow, and market trends
P3 Technologies
In November 2023, P3 Technologies was acquired by GHM
